Serum hepatitis B core antibody as the prognostic factor for diffuse large B-cell lymphoma

Serum hepatitis B core antibody as the prognostic factor for diffuse large B-cell lymphoma

ABSTRACT Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of non-Hodgkin lymphoma (NHL), strongly associated with viral infections. Although the link between hepatitis B virus (HBV) infection and DLBCL is well-documented, effective clinical markers reflecting HBV-associated DLBCL rem...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yi Rong, Ming Wang, Yaqiong Ma, Yuanchen Liang, Lvyin Ye, Lin Guo, Renquan Lu, Yanchun Wang
Format:	Article
Language:	English
Published:	American Society for Microbiology 2025-05-01
Series:	Microbiology Spectrum
Subjects:	hepatitis B virus diffuse large B-cell lymphoma hepatitis B core antibody CD23 prognosis
Online Access:	https://journals.asm.org/doi/10.1128/spectrum.03170-24
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Diffuse large B-cells lymphoma clinical features in patients with hepatitis B and C infection
by: G. I. Storozhakov, et al.
Published: (2022-11-01)

HBx integration in diffuse large B-cell lymphoma inhibits Caspase-3-PARP related apoptosis
by: Yanchun Wang, et al.
Published: (2024-12-01)

Prevalence of Hepatitis B Core Antibodies and Occult Hepatitis B Infection among Blood Donors in Erbil Governorate, Iraq
by: Nza Hamid Al-Barznjy, et al.
Published: (2025-07-01)

Henoch-Schönlein Purpura and Elevated Hepatitis C Virus Antibody in a Girl With Nasopharyngeal Diffuse Large B-Cell Lymphoma
by: Jen-Yin Hou, et al.
Published: (2011-12-01)

Robust in vitro assay for analyzing the neutralization activity of serum specimens against hepatitis B virus
by: Ya-Li Zhang, et al.
Published: (2019-01-01)

Hepatitis B and C infections among lymphoma patients: a national study in the Republic of Moldova
by: Ivan Negara, et al.
Published: (2022-12-01)

Plasma Epstein–Barr virus and Hepatitis B virus in non-Hodgkin lymphomas: Two lymphotropic, potentially oncogenic, latently occurring DNA viruses
by: Mahua Sinha, et al.
Published: (2016-01-01)

The significance of antibody to hepatitis B surface antigen in infection and clearance of hepatitis B virus
by: Ling Ding, et al.
Published: (2025-12-01)

A rare case of CD20− primary cutaneous diffuse large B-cell lymphoma, leg type
by: Juliette M. Kersten, MD, et al.
Published: (2024-12-01)

Some results of studying the effectiveness of vaccination against hepatitis B
by: L. V. Rubis
Published: (2020-06-01)

Serological pattern of anti-HBc alone infers occult hepatitis B virus infection in high-risk individuals in Iran
by: Amitis Ramezani, et al.
Published: (2010-10-01)

Case report: CAR-T therapy demonstrated safety and efficacy in relapsed/refractory diffuse large B-cell lymphoma patients complicated with hepatitis B-related cirrhosis
by: Danqing Kong, et al.
Published: (2024-12-01)

Investigation of hepatitis B surface antibody levels among preschool and school-age children in Tonglu County, Zhejiang Province
by: YE Yang, et al.
Published: (2025-02-01)

Prevalence of hepatitis B surface antibody among previously vaccinated healthcare workers in Tashkent, Uzbekistan
by: Rafail Ibragimov, et al.
Published: (2024-12-01)

Susceptibility to hepatitis B infection, hepatitis B/HIV co-infections and hepatitis B immunity in HIV-positive patients starting HAART in Durban, South Africa
by: F. M. Chonco, et al.
Published: (2019-04-01)

Hepatitis D virus antibodies and liver function profile among patients with chronic hepatitis B infection in Abuja, Nigeria
by: Lukman O Abdulkareem, et al.
Published: (2021-01-01)

Specific determination of hepatitis B e antigen by antibodies targeting precore unique epitope facilitates clinical diagnosis and drug evaluation against hepatitis B virus infection
by: Shao-Juan Wang, et al.
Published: (2021-01-01)

Induction of hepatitis B core protein aggregation targeting an unconventional binding site
by: Vladimir Khayenko, et al.
Published: (2025-03-01)

Treatment of chronic hepatitis B: options, monitoring, special cases and adverse effects
by: Mateusz Litwin Litwin, et al.
Published: (2025-01-01)

Optimal Use of Bispecific Antibodies for the Treatment of Diffuse Large B-Cell Lymphoma in Canada
by: Isabelle Fleury, et al.
Published: (2025-02-01)

Coexpression of CD5 and CD43 predicts worse prognosis in diffuse large B‐cell lymphoma
by: Xiao‐bo Ma, et al.
Published: (2018-09-01)

Cutaneous manifestations as the presenting signs of diffuse large B-cell lymphoma/high-grade B-cell lymphoma with MYC and BCL2 rearrangements
by: Gabriela Piñero-Crespo, BS, et al.
Published: (2025-01-01)

18F-FDG Whole-Body PET-MR in Primary Hepatic Lymphoma Mimicking Focal Nodular Hyperplasia
by: Shyma Basheer, et al.
Published: (2022-12-01)

Validation of quantitative hepatitis B virus DNA and hepatitis B e antigen titers in patients of chronic hepatitis B virus infection on entecavir therapy at tertiary care hospital
by: Diksha Budhani, et al.
Published: (2025-01-01)

Evaluation of the Effectiveness of Hepatitis B Vaccination in Children Aged 1 to 14 Years in Sulaimani City
by: Razhan Sabah Hassan, et al.
Published: (2023-04-01)

Therapeutic landscape of primary refractory and relapsed diffuse large B-cell lymphoma: Recent advances and emerging therapies
by: Allison M. Bock, et al.
Published: (2025-07-01)

Momentum towards simplifying and expanding treatment for chronic hepatitis B: The body of evidence continues to grow: Editorial on “Antiviral therapy for chronic hepatitis B with mildly elevated aminotransferase: A rollover study from the TORCH-B trial”
by: Robert J. Wong
Published: (2025-04-01)

Genetic variants of hepatitis B virus in patients with chronic hepatitis B
by: E. A. Elpaeva, et al.
Published: (2015-11-01)

Hepatitis B core-related antigen serum levels may be a predictor of acute flare of chronic hepatitis B among pregnant women in the immune-tolerant phase of chronic HBV infection after short-course antiviral therapy
by: Ruyu Liu, et al.
Published: (2023-12-01)

Correlation between serum quantitative HBsAg and HBV DNA levels in chronic hepatitis B patients
by: Pete Maria, et al.
Published: (2023-01-01)

Prospect of emerging treatments for hepatitis B virus functional cure
by: Rex Wan-Hin Hui, et al.
Published: (2025-02-01)

Vaccination Effect on Epidemic Process of Viral Hepatitis B In Republic of Belarus
by: V. S. Vysotskaya, et al.
Published: (2019-03-01)

Testicular diffuse large B-cell lymphoma. Clinical lecture and case report
by: K. B. Lelyavin, et al.
Published: (2023-12-01)

Presence of liver fibrosis in chronic hepatitis B patients with varying serum hepatitis B virus DNA levels: Letter to the editor on “Non-linear association between liver fibrosis scores and viral load in patients with chronic hepatitis B”
by: Jian Wang, et al.
Published: (2025-01-01)

Serologic and molecular characteristics of hepatitis B virus infection in vaccinated schizophrenia patients in China
by: Yiying Wang, et al.
Published: (2016-04-01)

The level of immunity against hepatitis B virus among employees of a police unit
by: Seyed Amin Mousavi Nezhad, et al.
Published: (2018-12-01)

Observation of genotype C infected chronic hepatitis B patients in clinical practice
by: Myo Nyein Aung, et al.
Published: (2011-11-01)

Vertical transmission of hepatitis B: the real and imaginary danger
by: M. A. Belopolskaya
Published: (2015-04-01)

Challenges in the Treatment of Acute Fulminant Hepatitis B: Case Report and Literature Review
by: Ali Alawieh, et al.
Published: (2014-08-01)

Seroprevalence of antibodies to hepatitis A, B and C viruses across all age groups in Chonburi Province, Thailand, 2022–2023
by: Nasamon Wanlapakorn, et al.
Published: (2025-12-01)